• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

GE completes two acquisitions

Article

Coincidence Technologies is now part of GE Medical Systems, and Kretztechnik is within a hair of joining it. Belgium-based Coincidence Technologies brings to GE technology for efficient manufacture of the PET radiopharmaceutical fluorodeoxyglucose (FDG)

Coincidence Technologies is now part of GE Medical Systems, and Kretztechnik is within a hair of joining it. Belgium-based Coincidence Technologies brings to GE technology for efficient manufacture of the PET radiopharmaceutical fluorodeoxyglucose (FDG) (SCAN 9/5/01). A synthesizer is used in conjunction with a cyclotron, providing the final chemical steps in producing the FDG. Austria-based Kretztechnik develops 3-D ultrasound systems. GE has acquired the 65.4% of Kretztechnik shares held by Medison, as well as another 27.1% of the company’s outstanding shares. These transactions provide GE with 92.5% ownership in Kretztechnik. After GE acquires the remaining shares, Kretztechnik will become a wholly owned subsidiary.

Related Videos
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.